These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10818496)

  • 1. Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury.
    Emmerling MR; Morganti-Kossmann MC; Kossmann T; Stahel PF; Watson MD; Evans LM; Mehta PD; Spiegel K; Kuo YM; Roher AE; Raby CA
    Ann N Y Acad Sci; 2000 Apr; 903():118-22. PubMed ID: 10818496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.
    Olsson A; Csajbok L; Ost M; Höglund K; Nylén K; Rosengren L; Nellgård B; Blennow K
    J Neurol; 2004 Jul; 251(7):870-6. PubMed ID: 15258792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury.
    Franz G; Beer R; Kampfl A; Engelhardt K; Schmutzhard E; Ulmer H; Deisenhammer F
    Neurology; 2003 May; 60(9):1457-61. PubMed ID: 12743231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort.
    Wang ML; Wei XE; Yu MM; Li PY; Li WB;
    Neurosci Lett; 2017 Aug; 655():115-120. PubMed ID: 28689050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
    Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
    J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of β-amyloid oligomers as a predictor of neurological outcome after brain injury.
    Gatson JW; Warren V; Abdelfattah K; Wolf S; Hynan LS; Moore C; Diaz-Arrastia R; Minei JP; Madden C; Wigginton JG
    J Neurosurg; 2013 Jun; 118(6):1336-42. PubMed ID: 23540266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cerebrospinal fluid biomarkers of neuronal injury or amyloidosis and cognitive decline after major surgery.
    Danielson M; Wiklund A; Granath F; Blennow K; Mkrtchian S; Nellgård B; Oras J; Fagerlund MJ; Granström A; Schening A; Rasmussen LS; Harris HE; Zetterberg H; Ricksten SE; Eriksson LI
    Br J Anaesth; 2021 Feb; 126(2):467-476. PubMed ID: 33183737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
    Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
    Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process.
    Sjögren M; Davidsson P; Gottfries J; Vanderstichele H; Edman A; Vanmechelen E; Wallin A; Blennow K
    Dement Geriatr Cogn Disord; 2001; 12(4):257-64. PubMed ID: 11351137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
    Delgado-Alvarado M; Gago B; Gorostidi A; Jiménez-Urbieta H; Dacosta-Aguayo R; Navalpotro-Gómez I; Ruiz-Martínez J; Bergareche A; Martí-Massó JF; Martínez-Lage P; Izagirre A; Rodríguez-Oroz MC
    Mov Disord; 2017 Jul; 32(7):1066-1073. PubMed ID: 28548309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.
    Alcolea D; Martínez-Lage P; Sánchez-Juan P; Olazarán J; Antúnez C; Izagirre A; Ecay-Torres M; Estanga A; Clerigué M; Guisasola MC; Sánchez Ruiz D; Marín Muñoz J; Calero M; Blesa R; Clarimón J; Carmona-Iragui M; Morenas-Rodríguez E; Rodríguez-Rodríguez E; Vázquez Higuera JL; Fortea J; Lleó A
    Neurology; 2015 Aug; 85(7):626-33. PubMed ID: 26180139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
    Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD
    J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.
    Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A
    CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
    Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Clark RS; Ruppel RA; Kochanek PM
    Pediatrics; 2002 Feb; 109(2):E31. PubMed ID: 11826241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
    Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
    Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury.
    Kay AD; Petzold A; Kerr M; Keir G; Thompson E; Nicoll JA
    J Neurotrauma; 2003 Oct; 20(10):943-52. PubMed ID: 14588111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function.
    Morganti-Kossmann MC; Hans VH; Lenzlinger PM; Dubs R; Ludwig E; Trentz O; Kossmann T
    J Neurotrauma; 1999 Jul; 16(7):617-28. PubMed ID: 10447073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.
    Hayakata T; Shiozaki T; Tasaki O; Ikegawa H; Inoue Y; Toshiyuki F; Hosotubo H; Kieko F; Yamashita T; Tanaka H; Shimazu T; Sugimoto H
    Shock; 2004 Aug; 22(2):102-7. PubMed ID: 15257081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.
    Csuka E; Morganti-Kossmann MC; Lenzlinger PM; Joller H; Trentz O; Kossmann T
    J Neuroimmunol; 1999 Nov; 101(2):211-21. PubMed ID: 10580806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans: a cohort study.
    Pikwer A; Castegren M; Namdar S; Blennow K; Zetterberg H; Mattsson N
    J Neuroinflammation; 2017 Sep; 14(1):193. PubMed ID: 28962579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.